StockNews.com Downgrades Ultralife (NASDAQ:ULBI) to Buy

Ultralife (NASDAQ:ULBIGet Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Thursday.

Separately, Benchmark lifted their price target on shares of Ultralife from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, June 27th.

View Our Latest Research Report on Ultralife

Ultralife Trading Up 0.9 %

NASDAQ:ULBI opened at $9.61 on Thursday. The company has a current ratio of 4.07, a quick ratio of 2.06 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $159.72 million, a PE ratio of 15.08 and a beta of 0.97. The firm’s 50 day moving average is $10.02 and its 200 day moving average is $10.36. Ultralife has a 12 month low of $6.36 and a 12 month high of $13.39.

Ultralife (NASDAQ:ULBIGet Free Report) last posted its quarterly earnings results on Thursday, July 25th. The technology company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08. The company had revenue of $42.98 million for the quarter. Ultralife had a net margin of 5.96% and a return on equity of 9.32%.

Institutional Investors Weigh In On Ultralife

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. ClariVest Asset Management LLC raised its holdings in Ultralife by 2.9% during the 2nd quarter. ClariVest Asset Management LLC now owns 66,657 shares of the technology company’s stock valued at $708,000 after acquiring an additional 1,864 shares during the period. Empowered Funds LLC grew its position in shares of Ultralife by 7.8% during the 1st quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after purchasing an additional 2,275 shares in the last quarter. Perritt Capital Management Inc. grew its position in shares of Ultralife by 25.0% during the 1st quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock valued at $132,000 after purchasing an additional 3,000 shares in the last quarter. Acadian Asset Management LLC grew its position in shares of Ultralife by 4.4% during the 2nd quarter. Acadian Asset Management LLC now owns 146,635 shares of the technology company’s stock valued at $1,556,000 after purchasing an additional 6,206 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Ultralife by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock valued at $4,545,000 after purchasing an additional 6,640 shares in the last quarter. Institutional investors own 30.68% of the company’s stock.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Further Reading

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.